FHH2 accounts for <5% of FHH cases and is due to loss-of-function mutations in the GNA11 gene that encodes the G-alpha subunit 11 (Gα11) protein, responsible for the CaSR downstream activation of phospholipase C [9]. Here, CASR is linked to familial hypocalciuric hypercalcemia.